Renhe Pharmacy Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 37.54%

Renhe Pharmacy Co Ltd (000650) has an Asset Resilience Ratio of 37.54% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Renhe Pharmacy Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥2.98 Billion

≈ $435.78 Million USD Cash + Short-term Investments

Total Assets

CN¥7.93 Billion

≈ $1.16 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2025)

This chart shows how Renhe Pharmacy Co Ltd's Asset Resilience Ratio has changed over time. See 000650 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Renhe Pharmacy Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Renhe Pharmacy Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.98 Billion	37.54%
Total Liquid Assets	CN¥2.98 Billion	37.54%

Asset Resilience Insights

Very High Liquidity: Renhe Pharmacy Co Ltd maintains exceptional liquid asset reserves at 37.54% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Renhe Pharmacy Co Ltd Industry Peers by Asset Resilience Ratio

Compare Renhe Pharmacy Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Chongqing Taiji Industry Group Co Ltd SHG:600129	Drug Manufacturers - Specialty & Generic	0.47%

Annual Asset Resilience Ratio for Renhe Pharmacy Co Ltd (2009–2025)

The table below shows the annual Asset Resilience Ratio data for Renhe Pharmacy Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	14.13%	CN¥1.09 Billion ≈ $159.95 Million	CN¥7.74 Billion ≈ $1.13 Billion	+0.54pp
2024-12-31	13.59%	CN¥1.02 Billion ≈ $148.83 Million	CN¥7.48 Billion ≈ $1.09 Billion	+1.24pp
2023-12-31	12.36%	CN¥919.96 Million ≈ $134.62 Million	CN¥7.44 Billion ≈ $1.09 Billion	+6.89pp
2022-12-31	5.46%	CN¥416.87 Million ≈ $61.00 Million	CN¥7.63 Billion ≈ $1.12 Billion	+0.89pp
2021-12-31	4.57%	CN¥315.60 Million ≈ $46.18 Million	CN¥6.91 Billion ≈ $1.01 Billion	-2.74pp
2020-12-31	7.31%	CN¥460.89 Million ≈ $67.44 Million	CN¥6.31 Billion ≈ $922.63 Million	-8.84pp
2019-12-31	16.15%	CN¥805.14 Million ≈ $117.82 Million	CN¥4.98 Billion ≈ $729.38 Million	+15.98pp
2018-12-31	0.17%	CN¥7.86 Million ≈ $1.15 Million	CN¥4.62 Billion ≈ $675.56 Million	-0.07pp
2017-12-31	0.24%	CN¥9.99 Million ≈ $1.46 Million	CN¥4.17 Billion ≈ $609.82 Million	+0.01pp
2016-12-31	0.23%	CN¥8.81 Million ≈ $1.29 Million	CN¥3.86 Billion ≈ $565.56 Million	-0.03pp
2015-12-31	0.26%	CN¥8.21 Million ≈ $1.20 Million	CN¥3.16 Billion ≈ $461.86 Million	+0.00pp
2014-12-31	0.26%	CN¥6.73 Million ≈ $985.27K	CN¥2.60 Billion ≈ $380.04 Million	+0.04pp
2013-12-31	0.22%	CN¥5.22 Million ≈ $763.17K	CN¥2.33 Billion ≈ $340.76 Million	-0.04pp
2012-12-31	0.26%	CN¥5.54 Million ≈ $810.28K	CN¥2.09 Billion ≈ $306.54 Million	-0.25pp
2011-12-31	0.52%	CN¥8.29 Million ≈ $1.21 Million	CN¥1.60 Billion ≈ $234.54 Million	-0.11pp
2010-12-31	0.63%	CN¥9.25 Million ≈ $1.35 Million	CN¥1.48 Billion ≈ $216.30 Million	-0.12pp
2009-12-31	0.74%	CN¥7.88 Million ≈ $1.15 Million	CN¥1.06 Billion ≈ $155.24 Million	--

pp = percentage points

About Renhe Pharmacy Co Ltd

SHE:000650 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.05 Billion

CN¥7.18 Billion CNY

Market Cap Rank

#8852 Global

#2215 in China

Share Price

CN¥5.13

Change (1 day)

-0.97%

52-Week Range

CN¥5.13 - CN¥7.02

All Time High

CN¥11.50